DRX DLY S&P Biotech Bull 3XETF
13F holders, Q1 2025 (March 31)6holders
0new positions
0sold out
$60.89avg. 13F price*
At the end of Q1 2025, 6 institutions reported holding DRX DLY S&P Biotech Bull 3X in their 13F filings, unchanged from Q4 2024. 0 opened new positions and 0 sold out. The largest holders were Lindbrook Capital, LLC ($152K), Parallel Advisors, LLC ($48K) and EverSource Wealth Advisors, LLC ($6K).
- Company
- DRX DLY S&P Biotech Bull 3X
- Filed as
- DIREXION DAILY S&P BIOTECH BULL 3X SHARES (Q1 2025)
- CUSIP
- 25490K323
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 1,750 shares bought and 28 shares sold, net +1,722 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Lindbrook Capital, LLC | 0.01% | Add +234.2% | 2,490 | $152K |
| Parallel Advisors, LLC | 0.00% | No change | 780 | $48K |
| EverSource Wealth Advisors, LLC | 0.00% | No change | 98 | $6K |
| Cornerstone Planning Group LLC | 0.00% | No change | 35 | $2K |
| Pension & Wealth Management Advisors, Inc. | 0.00% | Add +25.0% | 25 | $2K |
| Hollencrest Capital Management | 0.00% | Reduce -63.6% | 16 | $976 |
"% of holder's portfolio" is DRX DLY S&P BIOTECH BULL 3X's weight in each manager's 13F, not the share of DRX DLY S&P Biotech Bull 3X the manager owns.